Follow
Philip Jonsson
Philip Jonsson
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703-713, 2017
28922017
Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled …
H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ...
Journal of clinical oncology 36 (7), 633, 2018
12152018
The genomic landscape of endocrine-resistant advanced breast cancers
P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross, N Vasan, Y Cai, ...
Cancer cell 34 (3), 427-438. e6, 2018
7822018
Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
CC Coombs, A Zehir, SM Devlin, A Kishtagari, A Syed, P Jonsson, ...
Cell stem cell 21 (3), 374-382. e4, 2017
6552017
Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
EJ Jordan, HR Kim, ME Arcila, D Barron, D Chakravarty, JJ Gao, ...
Cancer discovery 7 (6), 596-609, 2017
5632017
Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade
W Abida, ML Cheng, J Armenia, S Middha, KA Autio, HA Vargas, ...
JAMA oncology 5 (4), 471-478, 2019
5272019
Genome doubling shapes the evolution and prognosis of advanced cancers
CM Bielski, A Zehir, AV Penson, MTA Donoghue, W Chatila, J Armenia, ...
Nature genetics 50 (8), 1189-1195, 2018
4672018
A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion–positive solid tumors
A Drilon, R Nagasubramanian, JF Blake, N Ku, BB Tuch, K Ebata, S Smith, ...
Cancer discovery 7 (9), 963-972, 2017
3782017
Tumour lineage shapes BRCA-mediated phenotypes
P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, ...
Nature 571 (7766), 576-579, 2019
3332019
Genetic predictors of response to systemic therapy in esophagogastric cancer
YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, ...
Cancer discovery 8 (1), 49-58, 2018
3082018
Accelerating discovery of functional mutant alleles in cancer
MT Chang, TS Bhattarai, AM Schram, CM Bielski, MTA Donoghue, ...
Cancer discovery 8 (2), 174-183, 2018
3052018
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
AM Schram, MT Chang, P Jonsson, A Drilon
Nature reviews Clinical oncology 14 (12), 735-748, 2017
2692017
Insufficient antibody validation challenges oestrogen receptor beta research
S Andersson, M Sundberg, N Pristovsek, A Ibrahim, P Jonsson, B Katona, ...
Nature communications 8 (1), 15840, 2017
2342017
Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3
P Dey, P Jonsson, J Hartman, C Williams, A Ström, JÅ Gustafsson
Molecular endocrinology 26 (12), 1991-2003, 2012
1452012
Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells
K Edvardsson, A Ström, P Jonsson, JÅ Gustafsson, C Williams
Molecular endocrinology 25 (6), 969-979, 2011
1372011
Genome-wide profiling of AP-1–regulated transcription provides insights into the invasiveness of triple-negative breast cancer
C Zhao, Y Qiao, P Jonsson, J Wang, L Xu, P Rouhi, I Sinha, Y Cao, ...
Cancer research 74 (14), 3983-3994, 2014
1342014
Marked response of a hypermutated ACTH-secreting pituitary carcinoma to ipilimumab and nivolumab
AL Lin, P Jonsson, V Tabar, TJ Yang, J Cuaron, K Beal, M Cohen, ...
The Journal of Clinical Endocrinology & Metabolism 103 (10), 3925-3930, 2018
1242018
Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
P Jonsson, AL Lin, RJ Young, NM DiStefano, DM Hyman, BT Li, ...
Clinical Cancer Research 25 (18), 5537-5547, 2019
1212019
AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated triple-negative breast cancer progression
Y Qiao, H He, P Jonsson, I Sinha, C Zhao, K Dahlman-Wright
Journal of Biological Chemistry 291 (10), 5068-5079, 2016
1202016
miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer
J Wang, E Tsouko, P Jonsson, J Bergh, J Hartman, E Aydogdu, ...
Molecular oncology 8 (8), 1690-1702, 2014
1162014
The system can't perform the operation now. Try again later.
Articles 1–20